Skip to content
DraconiticResearch
Search Sources API
190,839 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BY-NC 4.0The European Journal of Public Health

Burden of Childhood Central Nervous System Tumours through the European Cancer Information System

Abstract

Introduction: Although childhood cancers are rare, whereas represent an important cause of death in children. Central nervous system tumours (CNST) are the most common solid childhood tumours including heterogeneous histological subtypes. The European Cancer Information System (ECIS) integrates harmonized data from European Population-Based Cancer Registries (PBCRs). Assessing geographical variations and temporal trends is essential for surveillance and foresight in cancer control. This study analyses spatial and temporal patterns of childhood CNST incidence in Europe using ECIS data.

Methods: Age-standardised incidence rates (ASIRs) for children aged <15 years were obtained from ECIS, and 95% confidence intervals (95%CI) were computed. PBCRs updated to ≥ 2017 were included. Geographical analyses covered 2015–2021 (50 PBCRs, 19 countries). Temporal trends were assessed in 19 PBCRs with at least 10 consecutive three-year periods (1982–2023). Joinpoint regression estimated Average Annual Percent Change (AAPC).

Results: Astrocytoma was the most frequent subtype (20%–64%). Marked geographical variations were observed in overall CNST incidence, with ASIRs from 20 per million children-year (95%CI: 18.7–21.3) in Poland to 57.9 (95%CI: 49.7–66.1) in Emilia-Romagna. Astrocytoma ASIRs ranged from 9.1 (95%CI: 6.7–11.5) in Austria to 21.4 (95%CI: 17.2–25.6) in Croatia. Increasing trends were found in 12 PBCRs, with AAPCs between 2.4% (95%CI: 1.0–3.9) and 8.7% (95%CI: 1.6–16.5), mainly driven by other specified intracranial and intraspinal neoplasms in 11 PBCRs (AAPC: 7.6%–73.6%).

Conclusions: Childhood CNST incidence in Europe shows geographical variations and increasing trends in several PBCRs. ECIS supports on going childhood cancer monitoring; however, data for some countries such as France or Hungary are not updated, and for other such as Sweden or Luxembourg are not yet available, underscoring the need to strengthen data coverage across Europe.

Key messages: • Childhood central nervous system tumour incidence varies across Europe, with notable differences between population‑based cancer registries, and astrocytoma is the most frequent subtype.

• Data for several countries are either not updated or not available, underscoring the need to improve coverage among European population‑based cancer registries.

Related

  1. Liquid biopsy in solid tumours: expert opinion paper of the European society of pathology
    Nicola Fusco, Xavier Matias-Guiu, Irene Esposito +3
    Virchows ArchivPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  2. Central nervous system efficacy of third generation vs. first generation EGFR-TKIs in the first line treatment for EGFR-mutated non-small cell lung cancer with central nervous system metastases: a systematic review and meta-analysis of phase 3 randomized controlled trials
    Jiongli Gan, Shaofeng Zhu, Yan Fang +3
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Immune-Mediated Demyelinating Central Nervous System Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Journal of Brown hospital medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Late-Detected Sinus Venosus Atrial Septal Defect and Subsequent Enteroviral Central Nervous System Infection: A Case Report
    Aoumar G Chamma, Wendy Saliba, Linda Chamma
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. P108 Central nervous system lymphomatoid granulomatosis and toxoplasmosis in a patient with systemic lupus erythematosus and Sjögren disease: a diagnostic challenge
    Rheumatology advances in practicePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{gonzalezcanto2026burden,
  title = {{Burden of Childhood Central Nervous System Tumours through the European Cancer Information System}},
  author = {E González-Cantó and L Barrachina-Bonet and G Bargues-Navarro and N Canós-Puente and C Cavero-Carbonell and C Martos},
  journal = {The European Journal of Public Health},
  year = {2026},
  month = oct,
  doi = {10.1093/eurpub/ckag169.646},
  url = {https://doi.org/10.1093/eurpub/ckag169.646},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Burden of Childhood Central Nervous System Tumours through the European Cancer Information System
AU  - E González-Cantó
AU  - L Barrachina-Bonet
AU  - G Bargues-Navarro
AU  - N Canós-Puente
AU  - C Cavero-Carbonell
AU  - C Martos
PY  - 2026
DA  - 2026/10/01
JO  - The European Journal of Public Health
DO  - 10.1093/eurpub/ckag169.646
UR  - https://doi.org/10.1093/eurpub/ckag169.646
AB  - Introduction: Although childhood cancers are rare, whereas represent an important cause of death in children. Central nervous system tumours (CNST) are the most common solid childhood tumours including heterogeneous histological subtypes. The European Cancer Information System (ECIS) integrates harmonized data from European Population-Based Cancer Registries (PBCRs). Assessing geographical variations and temporal trends is essential for surveillance and foresight in cancer control. This study analyses spatial and temporal patterns of childhood CNST incidence in Europe using ECIS data.  Methods: Age-standardised incidence rates (ASIRs) for children aged <15 years were obtained from ECIS, and 95% confidence intervals (95%CI) were computed. PBCRs updated to ≥ 2017 were included. Geographical analyses covered 2015–2021 (50 PBCRs, 19 countries). Temporal trends were assessed in 19 PBCRs with at least 10 consecutive three-year periods (1982–2023). Joinpoint regression estimated Average Annual Percent Change (AAPC).  Results: Astrocytoma was the most frequent subtype (20%–64%). Marked geographical variations were observed in overall CNST incidence, with ASIRs from 20 per million children-year (95%CI: 18.7–21.3) in Poland to 57.9 (95%CI: 49.7–66.1) in Emilia-Romagna. Astrocytoma ASIRs ranged from 9.1 (95%CI: 6.7–11.5) in Austria to 21.4 (95%CI: 17.2–25.6) in Croatia. Increasing trends were found in 12 PBCRs, with AAPCs between 2.4% (95%CI: 1.0–3.9) and 8.7% (95%CI: 1.6–16.5), mainly driven by other specified intracranial and intraspinal neoplasms in 11 PBCRs (AAPC: 7.6%–73.6%).  Conclusions: Childhood CNST incidence in Europe shows geographical variations and increasing trends in several PBCRs. ECIS supports on going childhood cancer monitoring; however, data for some countries such as France or Hungary are not updated, and for other such as Sweden or Luxembourg are not yet available, underscoring the need to strengthen data coverage across Europe.  Key messages: • Childhood central nervous system tumour incidence varies across Europe, with notable differences between population‑based cancer registries, and astrocytoma is the most frequent subtype.  • Data for several countries are either not updated or not available, underscoring the need to improve coverage among European population‑based cancer registries.
SN  - 1101-1262
SN  - 1464-360X
ER  -